Vyas Lab

Twitter profile for Prof. Paresh Vyas research group at MRC Weatherall Institute of Molecular Medicine, University of Oxford

[Felix A. Radtke @FARadtke]

Lovely to see this one out in @Nature today:
@andygxzeng @MurtazaNagree @asger_jakobsen et al. identify an HSC subset retaining a molecular memory of inflammatory stress. A great collaboration between the @stephxie, John Dick, and @vyas_lab groups.

https://t.co/vJMVMhctsJ

[Felix A. Radtke @FARadtke]

Excited to see our study featured as a Plenary Paper in this week's issue of Blood @BloodPortfolio
https://t.co/aT9L5oSpKj

Podcast episode summarising the findings: https://t.co/VaB64LvVVH

[Sven Turkalj, PhD @SvenTurkalj]

Delighted to see that our work was selected as Plenary Paper in the new issue of Blood! We show that rapid clonal selection foreshadows outcome of IVO+VEN+/-AZA in AML and uncover transcriptional processes altered in resistant clones! @BloodPortfolio

https://t.co/tNWbwhN6To

[Sven Turkalj, PhD @SvenTurkalj]

Delighted to see our paper in @BloodPortfolio! Amazing collaboration between the teams in the @pvyas_oxford lab and the @MDAndersonNews! @FARadtke @BilyanaStoilova Rabea Mecklenbrauck @angusgroom Courtney DiNardo @mkonople @CLachowiez @sanamloghavi
🧵 about our main findings👇

[paresh vyas @pvyas_oxford]

Great collaboration with @MDAndersonNews courtney dinardo @mkonople @CLachowiez and the top crew in our lab esp @SvenTurkalj @FARadtke @BilyanaStoilova Rabea and @angusgroom
Data that has wide implications

[Felix A. Radtke @FARadtke]

🧵Just out in Blood @BloodPortfolio: Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy
https://t.co/aT9L5oSpKj

We study how resistance and durable remission emerge in IDH1-mutant AML.

[Verena Körber @VeKoerber]

Our paper on detecting and quantifying clonal selection from a single bulk sequencing sample is out! This was a great collaboration with @pvyas_oxford, Thomas Höfer, @asger_jakobsen and @NaserAnsariPour. Read the full story here: https://t.co/bpA30Lyy9Q

[MRC WIMM @MRC_WIMM]

@SvenTurkalj kicked off the first session with an excellent talk on his new genotyping method published in @CellStemCell last month 🎉

@MRC_MHU @vyas_lab

https://t.co/jMyukZ6sq6

[Vyas Lab @vyas_lab]

Well done, @GerdaMickute! You’re an asset to the lab 🙌🏻

[MRC WIMM @MRC_WIMM]

Congratulations to Prof. Irene Roberts and Prof. Paresh Vyas (@pvyas_oxford), who have been elected to Academy of Medical Sciences (@acmedsci) Fellowship! #AMSFellows2023

Read more here: https://t.co/GIDr3waii8

@MRC_MHU @RDMOxford @OxPaediatrics

[Sven Turkalj, PhD @SvenTurkalj]

Delighted to see our paper out today at @CellStemCell ! GTAC integrates #singlecell genotyping to chromatin accessibility profiling, linking genetic and epigenetic tumor evolution. Highlights👇
@pvyas_oxford @asger_jakobsen @angusgroom
https://t.co/fyB1WYXPIK

[Maria Chiara Barbanti @MChiaraBarbanti]

Best of ASH nomination for @SvenTurkalj 🙌🏻 @vyas_lab @UniofOxford

[Vyas Lab @vyas_lab]

Full house for @asger_jakobsen presenting his work on DNMT3A and TET2 mutations in CHIP. Very well done 👏🏻👏🏻

[Asger Jakobsen @asger_jakobsen]

Fantastic talk by @SvenTurkalj at #ASH22 this morning on our new GTAC method for combining high sensitivity genotyping with chromatin accessibility in single cells!

[Vyas Lab @vyas_lab]

Beautiful presentation on identification of GvL antigens in AML by Connor Sweeney at #ASH2022. Further work is ongoing! @UniofOxford @MRC_WIMM @MRC_MHU

[paresh vyas @pvyas_oxford]

Very well deserved best UK ASH abstract award for Asger Jakobsen!